Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boada

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Alzheimer'S Research & Therapy|August 18, 2021
Combination of white matter hyperintensities and Aβ burden is related to cognitive composites domain scores in subjective cognitive decline: the FACEHBI cohortG Ortega, A Espinosa, M Alegret, et al.
The Journal of Prevention of Alzheimer'S Disease|November 30, 2017
FACEHBI: A Prospective Study of Risk Factors, Biomarkers and Cognition in a Cohort of Individuals with Subjective Cognitive Decline. Study Rationale and Research ProtocolsO Rodriguez-Gomez, A Sanabria, A Perez-Cordon, et al.
Current Alzheimer Research|June 30, 2012
Progression of Alzheimer disease in Europe: data from the European ICTUS studyB Vellas, L Hausner, L Frölich, et al.
Alzheimer'S Research & Therapy|December 1, 2018
Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI)Itziar de Rojas, J Romero, O Rodríguez-Gomez, et al.
Molecular Psychiatry|March 16, 2016
Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairmentA Lacour, A Espinosa, E Louwersheimer, et al.
Molecular Psychiatry|July 17, 2013
ATP5H/KCTD2 locus is associated with Alzheimer's disease riskM Boada, C Antúnez, R Ramírez-Lorca, et al.
The Journal of Prevention of Alzheimer'S Disease|October 1, 2024
Progress in the Treatment of Alzheimer's Disease Is Needed - Position Statement of European Alzheimer's Disease Consortium (EADC) InvestigatorsF Jessen, M G Kramberger, D Angioni, et al.
Translational Psychiatry|February 6, 2014
Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility geneA Ruiz, S Heilmann, T Becker, et al.
Molecular Psychiatry|March 18, 2015
A novel Alzheimer disease locus located near the gene encoding tau proteinG Jun, C A Ibrahim-Verbaas, M Vronskaya, et al.
Nature Genetics|October 29, 2013
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's diseaseJ C Lambert, C A Ibrahim-Verbaas, D Harold, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Alzheimer'S Research & Therapy|August 18, 2021
Combination of white matter hyperintensities and Aβ burden is related to cognitive composites domain scores in subjective cognitive decline: the FACEHBI cohortG Ortega, A Espinosa, M Alegret, et al.
The Journal of Prevention of Alzheimer'S Disease|November 30, 2017
FACEHBI: A Prospective Study of Risk Factors, Biomarkers and Cognition in a Cohort of Individuals with Subjective Cognitive Decline. Study Rationale and Research ProtocolsO Rodriguez-Gomez, A Sanabria, A Perez-Cordon, et al.
Current Alzheimer Research|June 30, 2012
Progression of Alzheimer disease in Europe: data from the European ICTUS studyB Vellas, L Hausner, L Frölich, et al.
Alzheimer'S Research & Therapy|December 1, 2018
Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI)Itziar de Rojas, J Romero, O Rodríguez-Gomez, et al.
Molecular Psychiatry|March 16, 2016
Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairmentA Lacour, A Espinosa, E Louwersheimer, et al.
Molecular Psychiatry|July 17, 2013
ATP5H/KCTD2 locus is associated with Alzheimer's disease riskM Boada, C Antúnez, R Ramírez-Lorca, et al.
The Journal of Prevention of Alzheimer'S Disease|October 1, 2024
Progress in the Treatment of Alzheimer's Disease Is Needed - Position Statement of European Alzheimer's Disease Consortium (EADC) InvestigatorsF Jessen, M G Kramberger, D Angioni, et al.
Translational Psychiatry|February 6, 2014
Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility geneA Ruiz, S Heilmann, T Becker, et al.
Molecular Psychiatry|March 18, 2015
A novel Alzheimer disease locus located near the gene encoding tau proteinG Jun, C A Ibrahim-Verbaas, M Vronskaya, et al.
Nature Genetics|October 29, 2013
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's diseaseJ C Lambert, C A Ibrahim-Verbaas, D Harold, et al.
Pageof 8